Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure"

Neuro Oncol. 2014 May;16(5):617-8. doi: 10.1093/neuonc/nou050. Epub 2014 Apr 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Farnesyltranstransferase / antagonists & inhibitors*
  • Female
  • Humans
  • Male
  • Neurofibroma, Plexiform / drug therapy*
  • Neurofibromatosis 1 / drug therapy*
  • Quinolones / therapeutic use*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Quinolones
  • Farnesyltranstransferase
  • tipifarnib